Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

1.1K
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
1.1K
Effects of EDTA on End-Point Detection Methods01:18

Effects of EDTA on End-Point Detection Methods

819
Different methods, such as visual observance of metal-ion indicators, spectroscopic techniques, and potentiometric methods, can determine the endpoint of an EDTA titration.
In the visual method, metal-ion indicators (metallochromic dyes), which have distinct colors in their free and complex forms, are added to the mixture to signal the titration's end point. They form stable complexes with metal ions, but these complexes are weaker than the corresponding metal–EDTA complexes. As a...
819
Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

1.1K
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Social facilitation as a risk factor for alcohol misuse in young adults: study protocol for a prospective alcohol administration study.

BMC psychology·2026
Same author

Effects of nicotine concentration and pH on nicotine pouch appeal and sensory experience: A randomized experimental study.

Addiction (Abingdon, England)·2026
Same author

m-DASC: Measuring Subjective Effects of Very Low Doses of Psychedelic Drugs.

Psychedelic medicine (New Rochelle, N.Y.)·2026
Same author

Development of the MDMA-Assisted Psychotherapy Side Effects Tool (M-SET): a Delphi study.

BMJ open·2026
Same author

Acute and delayed effects of THC on memories of stress in healthy adults.

Psychopharmacology·2026
Same author

Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions, by Griffiths et al.

Psychedelic medicine (New Rochelle, N.Y.)·2026
Same journal

Effects of repeated treatment with opioids that vary in mu opioid receptor efficacy on pain-depressed locomotor behavior in mice.

Psychopharmacology·2026
Same journal

Cannabidiol in the anterior insular cortex attenuates chronic neuropathic pain and comorbid anxiety- and depression-like behaviors: involvement of CB<sub>1</sub> and 5-HT<sub>1A</sub> receptor signaling.

Psychopharmacology·2026
Same journal

Fentanyl decreases arterial blood oxygen saturation more than furanylfentanyl in mice due to increased apnea.

Psychopharmacology·2026
Same journal

Suicide attempt risk among patients receiving methylphenidate: a retrospective cohort study.

Psychopharmacology·2026
Same journal

Investigating the impact of serotonergic psychedelic drugs, MDMA and ketamine on social cognition in psychiatric disorders: A scoping review.

Psychopharmacology·2026
Same journal

OPRD1 rs4654327 and Outcomes of Extended-Release Naltrexone in Alcohol Use Disorder: An Exploratory Prospective Pharmacogenetic Study.

Psychopharmacology·2026
See all related articles

Related Experiment Video

Updated: May 2, 2026

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

11.3K

MDMA effects consistent across laboratories.

Matthew G Kirkpatrick1, Matthew J Baggott, John E Mendelson

  • 1Department of Psychiatry and Behavioral Neuroscience, University of Chicago, 5841 S. Maryland Ave., MC 3077, Chicago, IL, 60637, USA.

Psychopharmacology
|March 18, 2014
PubMed
Summary
This summary is machine-generated.

The acute effects of 3,4-methylenedioxymethamphetamine (MDMA) are reliable and reproducible across different research settings. Prior MDMA use showed a modest inverse relationship with perceived drug effects in experienced users, suggesting some tolerance.

More Related Videos

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones
06:06

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones

Published on: February 5, 2018

26.5K
MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
16:57

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease

Published on: February 14, 2012

28.9K

Related Experiment Videos

Last Updated: May 2, 2026

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

11.3K
Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones
06:06

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones

Published on: February 5, 2018

26.5K
MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease
16:57

MALDI Imaging Mass Spectrometry of Neuropeptides in Parkinson's Disease

Published on: February 14, 2012

28.9K

Area of Science:

  • Pharmacology
  • Neuroscience
  • Clinical Psychology

Background:

  • Placebo-controlled drug challenge studies with 3,4-methylenedioxymethamphetamine (MDMA) offer valuable data on its acute effects.
  • Examining MDMA's reliability across diverse subject samples and research settings is crucial for understanding its impact.

Purpose of the Study:

  • To assess the reproducibility of subjective and physiological responses to MDMA across three independent laboratories.
  • To investigate the influence of prior MDMA use on acute drug effects.

Main Methods:

  • 220 healthy volunteers with varied MDMA experience received placebo or MDMA (1.5 mg/kg or 125-mg fixed dose) orally under double-blind conditions.
  • Cardiovascular and subjective effects were monitored pre- and post-administration in studies conducted in Basel, San Francisco, and Chicago.
  • Methodological variations and participants' drug use histories were considered.

Main Results:

  • MDMA consistently produced similar cardiovascular and subjective effects across all three research sites, despite methodological differences.
  • Prior MDMA use was inversely associated with the perception of 'Any Drug Effect' exclusively in sites testing more experienced users.
  • These findings highlight the robustness of MDMA's pharmacological effects.

Conclusions:

  • The pharmacological effects of MDMA are robust and highly reproducible across different research settings.
  • Modest evidence suggests tolerance to MDMA's effects in individuals with regular drug use history.
  • These results underscore the reliability of MDMA challenge studies.